Loading...

APC anti-mouse CD3ε Antibody

Pricing & Availability
Clone
145-2C11 (See other available formats)
Regulatory Status
RUO
Other Names
CD3ε, T3, CD3
Isotype
Armenian Hamster IgG
Ave. Rating
Submit a Review
Product Citations
publications
145-2C11_APC_021606
C57BL/6 mouse splenocytes were stained with CD3e (clone 145-2C11) APC (filled histogram) or Armenian hamster IgG APC isotype control (open histogram).
  • 145-2C11_APC_021606
    C57BL/6 mouse splenocytes were stained with CD3e (clone 145-2C11) APC (filled histogram) or Armenian hamster IgG APC isotype control (open histogram).
See APC spectral data
Cat # Size Price Save
100311 25 µg ¥7,260
100312 100 µg ¥19,650
Description

CD3ε is a 20 kD transmembrane protein, also known as CD3 or T3. It is a member of the Ig superfamily and primarily expressed on T cells, NK-T cells, and at different levels on thymocytes during T cell differentiation. CD3ε forms a TCR complex by associating with the CD3δ, γ and ζ chains, as well as the TCR α/β or γ/δ chains. CD3 plays a critical role in TCR signal transduction, T cell activation, and antigen recognition by binding the peptide/MHC antigen complex.

Product Details
Technical data sheet

Product Details

Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Armenian Hamster
Immunogen
H-2Kb-specific mouse cytotoxic T lymphocyte clone BM10-37
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with APC under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The CD3ε antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤1.0 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

Clone 145-2C11 is useful for in vitro blocking of target-specific CTL-mediated cell lysis1, as well as T cell activation assays, inducing proliferation and cytokine production1,2,7,12,16. It also induces apoptosis in immature thymocytes32,  and in vivo T cell depletion8-10. Additional reported applications (for relevant formats of this clone) include: immunoprecipitation1, immunohistochemical staining14,15 of acetone-fixed frozen sections and zinc-fixed paraffin-embedded sections, Western blotting4, complement-mediated cytotoxicity6, in vitro and in vivo stimulation of T cells1,2,7,12,16, immunofluorescent staining5, and in vivo T cell depletion8-10. The 145-2C11 antibody has been reported to block the binding of 17A2 antibody to CD3 epsilon-specific T cells11. Clone 145-2C11 is not recommended for formalin-fixed paraffin embedded sections. The LEAF™ purified antibody (Endotoxin <0.1 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 100314). For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Cat. No. 100340) with a lower endotoxin limit than standard LEAF™ purified antibodies (Endotoxin <0.01 EU/µg).

Application References

(PubMed link indicates BioLegend citation)
  1. Leo O, et al. 1987. P. Natl. Acad. Sci. USA 84:1374. (IP, Activ, Block)
  2. Kruisbeek AM, et al. 1991. In Current Protocols in Immunology. 3.12.1. (Activ)
  3. Duke RC, et al. 1995. Current Protocols in Immunology. 3.17.1.
  4. Salvadori S, et al. 1994. J. Immunol. 153:5176. (WB)
  5. Payer E, et al. 1991. J. Immunol. 146:2536. (IF)
  6. Jacobs H, et al. 1994. Eur. J. Immunol. 24:934. (CMCD)
  7. Vossen ACTM, et al. 1995. Eur. J. Immunol. 25:1492. (Activ)
  8. Henrickson M, et al. 1995. Transplantation 60:828. (Deplete)
  9. Kinnaert P, et al. 1996. Transpl. Int. 9:386. (Deplete)
  10. Han WR, et al. 1999. Transpl. Immunol. 7:207. (Deplete)
  11. Miescher GC, et al. 1989. Immunol. Lett. 23:113. (Block)
  12. Terrazas LI, et al. 2005. Intl. J. Parasitology. 35:1349. (Activ)
  13. Ko SY, et al. 2005. J. Immunol. 175:3309.
  14. Podd BS, et al. 2006. J. Immunol. 176:6532. (IHC-F)
  15. Tilley SL, et al. 2007. J. Immunol. 178:3208. (IHC-F)
  16. Wang W, et al. 2007. J. Immunol. 178:4885. (Activ)
  17. Xiao S, et al. 2007. J. Exp. Med. 204:1691.
  18. Chappaz S, et al. 2007. Blood doi:10.1182/blood-2007-02-074245. (FC) PubMed.
  19. Curtsinger JM, et al.2005. J. Immunol. 175:4392. PubMed
  20. Guo Y, et al. 2008. Blood 112:480. PubMed
  21. Kenna TJ, et al. 2008. Blood 111:2091.
  22. Perchonock CE, et al. 2007. J. Immunol. 179:1768. PubMed
  23. Perchonock GE, et al. 2006. Mol. Cell. Biol. 26:6005. PubMed
  24. Kanaya T, et al. 2008. Am. J. Physiol. Gastrointest. Liver Physiol. 295:G273. PubMed
  25. de Koning BA, et al. 2006. Int. Immunol. 18:941. PubMed
  26. Schulteis RD, et al. 2008. Blood 295:G273. PubMed
  27. Qi Q, et al. 2009. Blood 114:564. PubMed
  28. Helmersson S, et al. 2013. Am J Pathol. 9440:123. Pubmed
  29. Wu S, et al. 2014. Clin Vaccine Immunol. 21:156. PubMed
  30. Yan J, et al. 2014. Vaccine. 32:2833. PubMed
  31. Guiterrez DA, et al. 2014. Diaebetes. 63:3827. PubMed
  32. Shi YF, et al. 1991. J Immunol. 146:3340. (Apop)
Product Citations
  1. Glasner A,et al. 2017. Sci Rep.. 10.1038/s41598-017-12998-w. PubMed
  2. Wang J, et al. 2018. Front Immunol. 9:371. PubMed
  3. Liu S, et al. 2018. Front Immunol. 29:208. PubMed
  4. Xia P et al. 2018. Immunity. 48(4):688-701 . PubMed
  5. Gubin MM, et al. 2018. Cell. 175:1014. PubMed
  6. Metidji A et al. 2018. Immunity. 49(2):353-362 . PubMed
  7. Celik H, et al. 2018. Cancer Cell. 34:741. PubMed
  8. Kang YH, et al. 2019. Nat Commun. 10:912. PubMed
  9. Tong Y, et al. 2018. EBioMedicine. 39:132. PubMed
  10. Agelidis A, et al. 2019. Front Immunol. 10:500. PubMed
  11. Ajina R, et al. 2019. Oncoimmunology. 8:e1577127. PubMed
  12. Timilshina M, et al. 2020. Cell Reports. 27(10):2948-2961.e7.. PubMed
  13. Omenetti S, et al. 2019. Immunity. 51:77. PubMed
  14. Radulovic V, et al. 2020. Cell Reports. 27(10):2826-2836.e5.. PubMed
  15. Codina A, et al. 2019. Cell Syst. 8:136. PubMed
  16. Gorczynski RM, et al. 2017. Immunology. 150:418. PubMed
  17. Parks CA, et al. 2019. Proc Natl Acad Sci U S A. 116:3136. PubMed
  18. Fujita K, et al. 2019. Proc Natl Acad Sci U S A. 116:14714. PubMed
  19. Chan LC, et al. 2019. J Clin Invest. 129:3324. PubMed
  20. Zhang H, et al. 2019. Mol Cell. 76:110. PubMed
  21. Gao JL, et al. 2019. JCI Insight. 4:e132140. PubMed
  22. Lercher A, et al. 2019. Immunity. 51:1074. PubMed
  23. Castañeda–Zegarra S, et al. 2019. Biomolecules. 0.929166667. PubMed
  24. Ghandhi SA, et al. 2019. Sci Rep. 9:19434. PubMed
  25. Casanova-Acebes M, et al. 2018. J Exp Med. 215:2778. PubMed
  26. Ulaganathan VK, et al. 2020. Sci Rep. 10:8453. PubMed
  27. Parhi L, et al. 2020. Nat Commun. 2.721527778. PubMed
  28. Yu YR, et al. 2020. STAR Protocols. 11(3):e0150606. PubMed
  29. McCauley ME, et al. 2020. Nature. 585(7823):96-101. PubMed
  30. Liu Z, et al. 2020. Cell. 178(6):1509-1525.e19.. PubMed
  31. Dong MB, et al. 2020. Cell. 178(5):1189-1204.e23.. PubMed
  32. Xu H, et al. 2020. Immunity. 51(4):696-708.e9.. PubMed
  33. Arensman MD, et al. 2020. Oncoimmunology. 9:1800162. PubMed
  34. Liu Z, et al. 2020. STAR Protoc. 1:100029. PubMed
  35. Huang J, et al. 2014. J Immunol. 192:1972. PubMed
  36. Okamoto M, et al. 2014. J Immunol. 192:2770. PubMed
  37. Zhu E, et al. 2014. J Immunol. 192:5599. PubMed
  38. Aebischer D, et al. 2014. PLoS One. 9:99297. PubMed
  39. Bergquist M, et al. 2014. J Infect. 69:113. PubMed
  40. Pennock N, et al. 2014. Proc Natl Acad Sci U S A. 111:16472. PubMed
  41. Nakamura M, et al. 2015. J Immunol. 194:243. PubMed
  42. Burrack K, et al. 2015. J Immunol. 194:678. PubMed
  43. Wan W, et al. 2015. Cardiovasc Res. 106:478. PubMed
  44. Luck H, et al. 2015. Cell Metab. 21 527 . PubMed
  45. XS R, et al. 2015. Diabetes. 64 90. PubMed
  46. Sato K, et al. 2015. PLoS One. 10: 0138291. PubMed
  47. Siggs O, et al. 2015. Proc Natl Acad Sci U S A. 112: E5706 - E5714. PubMed
  48. Burrack K, et al. 2015. PLoS Pathog. 11: e1005191. PubMed
  49. Ito C, et al. 2015. PLoS One. 10: e0140808. PubMed
  50. Xu G, et al. 2015. Free Radic Biol Med. 87: 15-25. PubMed
  51. Holvoet B, et al. 2015. Stem Cell Reports. 5: 1183-1195. PubMed
  52. Rovira-Clavé X, et al. 2016. J Leukoc Biol. 99: 143 - 152. PubMed
  53. Leiva M, et al. 2016. Nat Commun. 7:10222. PubMed
  54. Pelly V, et al. 2016. Mucosal Immunol. 10.1038/mi.2016.4. PubMed
  55. Uto T, et al. 2016. Nat Commun. 7: 11273. PubMed
  56. Cruz F, et al. 2016. Stem Cells Trans Med. 5: 488-499. PubMed
  57. Campisi L, et al. 2016. Nat Immunol. 10.1038/ni.3512. PubMed
  58. Barrett N, et al. 2016. Cell Rep. 16: 1039-1054. PubMed
  59. Ku M, et al. 2016. Mol Cancer Ther. 15: 1975 - 1987. PubMed
  60. Wang Y, et al. 2016. Sci Rep. 6:31881. PubMed
  61. Roufaiel M, et al. 2016. Nat Immunol. 10.1038/ni.3564. PubMed
  62. Miura N, et al. 2017. Mol Ther. 10.1016/j.ymthe.2017.01.020. PubMed
  63. Harvey RE et al. 2017. Endocrinology. 158(7):2179-2189 . PubMed
  64. Gong N, et al. 2020. Nat Nanotechnol. 1.35625. PubMed
  65. Montel-Hagen A, et al. 2020. Cell Rep. 33:108320. PubMed
  66. Nosho S, et al. 2020. Int J Mol Sci. 21:00. PubMed
  67. Ferrari de Andrade L, et al. 2020. Cancer Immunol Res. 0.867361111. PubMed
  68. Nahrendorf W, et al. 2021. eLife. 10:00. PubMed
  69. Ringel AE, et al. 2020. Cell. 183(7):1848-1866.e26. PubMed
  70. Delacher M, et al. 2021. Immunity. 54(4):702-720.e17. PubMed
  71. Altshuler A, et al. 2021. Cell Stem Cell. 28(7):1248-1261.e8. PubMed
  72. Huang X, et al. 2021. Immunity. . PubMed
  73. Haugh KA, et al. 2021. eLife. 0.416666666666667. PubMed
  74. Mansell E, et al. 2020. Cell Stem Cell. . PubMed
  75. Bonavita E, et al. 2020. Immunity. 1215:53. PubMed
  76. Onai N, et al. 2020. Int J Mol Sci. :22. PubMed
  77. Yang X, et al. 2021. Bioact Mater. 3150:6. PubMed
  78. Liang Q, et al. 2020. Front Microbiol. 11:571847. PubMed
  79. Dong S, et al. 2021. Nature. 591:117. PubMed
  80. Shi GN, et al. 2021. Ther Adv Med Oncol. 13:1758835920987056. PubMed
  81. Rousso-Noori L, et al. 2021. Nat Commun. 12:3615. PubMed
  82. Shibuya M, et al. 2021. iScience. 24:103131. PubMed
  83. Symeonidou V, et al. 2021. Cell Rep. 37:109900. PubMed
  84. Wang Q, et al. 2020. Radiat Environ Biophys. 59:89. PubMed
  85. Ma J, et al. 2020. Adv Sci (Weinh). 7:2000609. PubMed
  86. Berghoff SA, et al. 2021. Nat Neurosci. 24:47. PubMed
  87. Zhang X, et al. 2021. Mol Cancer Res. 19:1076. PubMed
  88. Wang W, et al. 2021. J Am Heart Assoc. 10:e019142. PubMed
  89. Koide S, et al. 2022. iScience. 25:103603. PubMed
  90. Oksenych V, et al. 2021. Biomolecules. 12:. PubMed
  91. Bajaña S, et al. 2022. iScience. 25:103732. PubMed
  92. Volpedo G, et al. 2022. NPJ Vaccines. 7:32. PubMed
  93. Omatsu Y, et al. 2022. Nat Commun. 13:2654. PubMed
  94. Dourcy M, et al. 2020. Mucosal Immunol. 13:799. PubMed
  95. Dane EL, et al. 2022. Nat Mater. 21:710. PubMed
  96. , et al. 2021. Eur J Immunol. 51:2708. PubMed
  97. Mittal A, et al. 2021. Sci Rep. 11:10731. PubMed
  98. Jing Y, et al. 2021. Front Immunol. 12:651860. PubMed
  99. Shaikh H, et al. 2021. Front Immunol. 12:689896. PubMed
  100. Wang Y, et al. 2021. Nat Commun. 12:4964. PubMed
  101. Fujimori S, et al. 2022. Elife. 11:. PubMed
  102. Zhang Q, et al. 2022. JCI Insight. 7:. PubMed
  103. Sun Y, et al. 2022. Mol Ther Oncolytics. 25:160. PubMed
  104. Mukherjee D, et al. 2022. Nat Commun. 13:3747. PubMed
  105. Zhou S, et al. 2021. Adv Funct Mater. 31:. PubMed
  106. Gu X, et al. 2022. Vaccines (Basel). 10:. PubMed
  107. Hum NR, et al. 2022. Front Oncol. 12:928474. PubMed
  108. Liu B, et al. 2022. Mol Med Rep. 26:. PubMed
  109. Ghandhi SA, et al. 2022. Sci Rep. 12:14124. PubMed
  110. Sun Y, et al. 2022. iScience. 25:104846. PubMed
  111. Yang Z, et al. 2022. J Immunother Cancer. 10:. PubMed
  112. Yang W, et al. 2020. Mucosal Immunol. 13:788. PubMed
  113. Yamaguchi S, et al. 2021. Eur J Immunol. 51:2306. PubMed
  114. Zhou H, et al. 2022. EMBO Rep. 23:e53475. PubMed
  115. Jung BG, et al. 2022. PLoS Pathog. 18:e1010454. PubMed
  116. Zhang CR, et al. 2022. Blood Cancer Discov. 3:220. PubMed
  117. Yang X, et al. 2020. Blood Sci. 2:89. PubMed
  118. Li D, et al. 2022. Emerg Microbes Infect. 11:2248. PubMed
  119. Stephens HM, et al. 2022. Methods Mol Biol. 2478:727. PubMed
  120. Düking T, et al. 2022. Sci Adv. 8:eabo7639. PubMed
  121. Chryplewicz A, et al. 2022. Cancer Cell. 40:1111. PubMed
  122. Liu Y, et al. 2022. Am J Transl Res. 14:6856. PubMed
  123. Lopez DA, et al. 2022. Cell Rep. 41:111677. PubMed
  124. Sato Y, et al. 2022. Front Mol Biosci. 9:1040237. PubMed
  125. Nelson J, et al. 2020. Sci Adv. 6:eaaz6893. PubMed
  126. Li H, et al. 2022. Cancer Cell. 40:36. PubMed
  127. Wang B, et al. 2022. EMBO J. 41:e108946. PubMed
  128. Koenig A, et al. 2022. Front Immunol. 12:791100. PubMed
  129. Cha JH, et al. 2022. J Biol Chem. 298:101817. PubMed
  130. Khayrullina G, et al. 2022. Glia. 70:1337. PubMed
  131. Gargaro M, et al. 2022. Immunity. 55:1032. PubMed
  132. Chen C, et al. 2022. Sci Adv. 8:eabo4363. PubMed
  133. Kumpunya S, et al. 2023. Front Immunol. 13:1010764. PubMed
  134. Sieow JL, et al. 2023. Int J Mol Sci. 24: . PubMed
  135. Agrafiotis A, et al. 2023. Acta Neuropathol. 145:335. PubMed
  136. Kemna J, et al. 2023. Nat Immunol. 24:414. PubMed
  137. Drijvers JM, et al. 2021. Cancer Immunol Res. 9:184. PubMed
  138. Sohn J, et al. 2022. Blood Adv. 6:2557. PubMed
  139. Zhu Z, et al. 2022. Clin Cancer Res. 28:4820. PubMed
  140. Zhuang WR, et al. 2023. Nat Commun. 14:1675. PubMed
  141. van Os BW, et al. 2023. Eur Heart J Open. 3:oead013. PubMed
  142. Seclì L, et al. 2023. J Immunother Cancer. 11:. PubMed
  143. van Os BW, et al. 2023. Front Cardiovasc Med. 10:1171764. PubMed
RRID
AB_312676 (BioLegend Cat. No. 100311)
AB_312677 (BioLegend Cat. No. 100312)

Antigen Details

Structure
Ig superfamily, forms CD3/TCR complex with CD3δ, γ and ζ subunits and TCR (α/β and γ/δ), 20 kD
Distribution

Thymocytes (differentiation dependent), mature T cells, NK-T cells

Function
TCR signal transduction, T cell activation, antigen recognition
Ligand/Receptor
Peptide antigen/MHC-complex
Cell Type
NKT cells, T cells, Thymocytes, Tregs
Biology Area
Immunology
Molecular Family
CD Molecules, TCRs
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Davis MM. 1990. Annu. Rev. Biochem. 59:475.
3. Weiss A, et al. 1994. Cell 76:263.

Gene ID
12501 View all products for this Gene ID
UniProt
View information about CD3epsilon on UniProt.org

Related FAQs

There are no FAQs for this product.
Go To Top Version: 1    Revision Date: 11/30/2012

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account